Skip to content

Avanos Medical AVNS Earnings yield

Earnings yield at other companies

Stryker logo
StrykerSYK
2.7%+0.6pp
Cardinal Health logo
Cardinal HealthCAH
3.1%-1.6pp
Boston Scientific logo
Boston ScientificBSX
3.8%+2.5pp
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
0.6%
Medtronic logo
MedtronicMDT
4.6%+0.3pp
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
7.1%+2.6pp

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Calculated from Avanos Medical’s reported figures.

Based on trailing twelve months.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's earnings yield?
Avanos Medical (AVNS) reported earnings yield of -11.4% in Q1 2026.
How has Avanos Medical's earnings yield changed year-over-year?
Avanos Medical's earnings yield increased by 80.4% year-over-year, from -58.3% to -11.4%.
What is the long-term trend for Avanos Medical's earnings yield?
Over 4 years (2020 to 2025), Avanos Medical's earnings yield has grown at a 80.7% compound annual growth rate (CAGR), from -1.3% to -14%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.